| Not Yet Recruiting | Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets T2DM (Type 2 Diabetes Mellitus) | Phase 1 | 2026-10-08 |
| Not Yet Recruiting | Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets T2DM (Type 2 Diabetes Mellitus) | N/A | 2026-07-09 |
| Not Yet Recruiting | Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets T2DM (Type 2 Diabetes Mellitus) | N/A | 2026-05-27 |
| Not Yet Recruiting | Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Duct Metastatic Pancreatic Ductal Adenocarcinoma | Phase 3 | 2026-03-31 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasi Plaque Psoriasis | Phase 1 / Phase 2 | 2025-09-08 |
| Recruiting | Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of Lymphoma, T-Cell, Peripheral | Phase 3 | 2025-08-12 |
| Recruiting | Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors Neoplasms, Glioblastoma, Adult, Small Cell Lung Carcinoma (SCLC) | Phase 1 | 2025-05-21 |
| Recruiting | A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients Colorectal Cancer | Phase 3 | 2024-12-06 |
| Active Not Recruiting | Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma Pancreatic Ductal Adenocarcinoma | Phase 2 | 2024-08-13 |
| Completed | A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic Profiles and Food Effec Healthy | Phase 1 | 2024-03-28 |
| Recruiting | A Study of CS23546 in Subjects With Advanced Tumors Advanced Tumors | Phase 1 | 2024-03-27 |
| Recruiting | A Study of NWY001 in Subjects With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2024-01-05 |
| Completed | A Clinical Trial of CS12192 in Healthy Subjects Healthy | Phase 1 | 2023-07-20 |
| Completed | Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects. T2DM | Phase 1 | 2023-02-17 |
| Completed | Pharmacokinetics of Chiglitazar in Subjects With Hepatic Impairment and Normal Hepatic Function Hepatic Impairment | Phase 1 | 2022-12-03 |
| Completed | Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal Function Renal Impairment | Phase 1 | 2022-11-20 |
| Active Not Recruiting | A Study of Tucidinostat Combined With Tislelizumab as First-line Treatment in Advanced NSCLC Non Small Cell Lung Cancer | Phase 2 | 2022-10-26 |
| Recruiting | Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC. Small Cell Lung Cancer, Advanced Solid Malignant Tumor | Phase 1 / Phase 2 | 2022-08-26 |
| Completed | Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS) Soft Tissue Sarcoma | Phase 2 | 2022-08-25 |
| Completed | Mass Balance Study of [14C]Chiauranib Small Cell Lung Cancer | N/A | 2022-07-20 |
| Completed | Trial of Chiauranib Capsule on Pharmacokinetics to Assess the Effect of High Fat Diet in Healthy Volunteers Healthy Volunteers | Phase 1 | 2022-06-02 |
| Completed | A Phase II Clinical Trial of Chiglitazar for NASH NASH | Phase 2 | 2022-03-21 |
| Recruiting | Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Ovarian Cancer, Relapsed or Refractory, Chiauranib | Phase 3 | 2021-12-20 |
| Completed | Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC. Non Small Cell Lung Cancer | Phase 2 | 2021-11-23 |
| Terminated | A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC Triple-negative Breast Cancer | Phase 2 | 2021-11-05 |
| Completed | Chiglitazar Added to Metformin for Type 2 Diabetes Type 2 Diabetes | Phase 3 | 2021-07-06 |
| Completed | Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer Small Cell Lung Cancer | Phase 3 | 2021-03-05 |
| Completed | Phase III Study of Tucidinostat in Combination With R-CHOP in Patients With Newly Diagnosed Double-Expressor D Diffuse Large B-cell Lymphoma | Phase 3 | 2020-05-21 |
| Completed | Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma Non-hodgkin's Lymphoma | Phase 1 / Phase 2 | 2019-07-11 |
| Completed | Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer Ovarian Cancer | Phase 2 | 2019-07-01 |
| Completed | Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2018-04-28 |
| Completed | Phase Ib Study of Chiauranib in Patients With Ovarian Cancer Ovarian Cancer | Phase 1 / Phase 2 | 2017-12-15 |
| Completed | Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer Small Cell Lung Cancer | Phase 1 | 2017-11-09 |
| Terminated | Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's Lymphoma Non-Hodgkin's Lymphoma | Phase 1 | 2017-05-09 |
| Completed | Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients Peripheral T-cell Lymphoma | Phase 1 | 2016-08-11 |
| Completed | Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer Breast Cancer | Phase 3 | 2015-07-01 |
| Completed | Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients Type 2 Diabetes | Phase 3 | 2014-09-01 |
| Completed | Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients Type 2 Diabetes | Phase 3 | 2014-06-01 |
| Completed | Phase I Study of Chiauranib in Patients With Advanced Solid Tumors Solid Tumors | Phase 1 | 2014-02-01 |
| Completed | Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer Non-small-cell Lung Cancer | Phase 2 | 2013-04-01 |